 Connection
Reema Wahdan-Alaswad to TOR Serine-Threonine Kinases
This is a "connection" page, showing publications Reema Wahdan-Alaswad has written about TOR Serine-Threonine Kinases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.613 |
|
|
|
-
Wahdan-Alaswad RS, Bane KL, Song K, Shola DT, Garcia JA, Danielpour D. Inhibition of mTORC1 kinase activates Smads 1 and 5 but not Smad8 in human prostate cancer cells, mediating cytostatic response to rapamycin. Mol Cancer Res. 2012 Jun; 10(6):821-33.
Score: 0.301
-
Wahdan-Alaswad RS, Song K, Krebs TL, Shola DT, Gomez JA, Matsuyama S, Danielpour D. Insulin-like growth factor I suppresses bone morphogenetic protein signaling in prostate cancer cells by activating mTOR signaling. Cancer Res. 2010 Nov 15; 70(22):9106-17.
Score: 0.273
-
Song K, Shankar E, Yang J, Bane KL, Wahdan-Alaswad R, Danielpour D. Critical role of a survivin/TGF-ß/mTORC1 axis in IGF-I-mediated growth of prostate epithelial cells. PLoS One. 2013; 8(5):e61896.
Score: 0.020
-
Deng XS, Wang S, Deng A, Liu B, Edgerton SM, Lind SE, Wahdan-Alaswad R, Thor AD. Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers. Cell Cycle. 2012 Jan 15; 11(2):367-76.
Score: 0.019
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|